- HK$594.67m
- HK$665.61m
- CNY1.38bn
Brief: Gaush Meditech's Diagnostic Devices For Dry Eyes Obtains Medical Device Registration Certificates
Brief: Gaush Meditech Announces Intention To Conduct On-Market Share Repurchase
Brief: Gaush Meditech Says Aspheric Intraocular Lens Obtained NMPA Medical Device Registration Certificate
Brief: Gaush Meditech Says Gao Tieta Has Ceased To Act As CEO
Brief: Gaush Meditech Declares Final Dividend Of HK$1.1 Per Share
Gaush Meditech jumps most in 7 weeks on robust earnings outlook
Brief: Gaush Meditech Sees Net Profit Of RMB164.3-181.5 Million For 2023
Brief: Gaush Meditech Says Gaush Netherlands Was Granted By Bank, Among Others A Facility Of Eur52.5 Million
Brief: Gaush Meditech Says Rigid Contact Lenses Obtained NMPA Medical Device Registration Certificate
Brief: Gaush Meditech Posts HY Net Profit RMB110.4 Million
Brief: Gaush Meditech Says Li Wenqi Appointed As Executive Director
Brief: Gaush Meditech Says HK$185 Mln Facility Granted By Credit Suisse To GT Holdco Had Been Fully Repaid
Brief: Gaush Meditech Sees Net Loss Of RMB335.3 Million To RMB370.5 Million For FY
Brief: Gaush Meditech Says Unit Entered Framework Cooperation Agreement With Geuder AG
Brief: Gaush Meditech Says Inclusion As Eligible Stock Of Shanghai-Hong Kong Stock Connect And Others
Brief: Gaush Meditech Enters Certain License Agreements With SBM Sistemi S.R.L.
Brief: Gaush Meditech Says Li Wenqi Appointed As Chief Financial Officer
Brief: Gaush Meditech Updates On Charge Of Shares By Controlling Shareholder